WHO ICTRP trial

FRIZ Biochem Clinical Performance Study EU IVDR for CYCLE® Dx System Respiratory…

DRKS00032909 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00032909
Public title FRIZ Biochem Clinical Performance Study EU IVDR for CYCLE® Dx System Respiratory Viruses (CliPReV)
Scientific title FRIZ Biochem Clinical Performance Study EU IVDR for CYCLE® Dx System Respiratory Viruses (CliPReV) - CliPReV
Primary sponsor FRIZ Biochem GmbH
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions Viruses studied: Influenza A & B, RSV, SARS-CoV-2
Interventions Group 1: Evaluation of the clinical performance of the CYCLE® Dx system in accordance with Regulation (EU) 2017/746. This clinical performance evaluation compares the diagnostic sensitivity and diagnostic specificity of the CYCLE® Dx system…
Registration date Nov 3, 2024
Target size 1200
Secondary IDs CIV-23-10-044414
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations